College News
Performance and workshop focus on why art matters in medicine
Performance artist Marina Tsaplina, who has lived with Type 1 diabetes since she was 2, attempted to unpack the question — What does art do, and why does it matter in medicine? — at a recent event at UNC-Chapel Hill.
200 Years of Carolina Chemistry
Exum) In April, Carolina chemistry will celebrate its 200th birthday. A key secret to reaching this venerable milestone and achieving an international reputation has been to invest in generations of promising young scientists like Bo Li and to provide them with the tools they need to thrive. Today, young scholars continue to work alongside foundational members of the department — … Continued
UNC student leaders meet with CEO, founder of Schwarzman Scholars
Stephen Schwarzman, Chairman, CEO and co-founder of Blackstone, one of the world’s largest investment firms, visited UNC-Chapel Hill recently and talked leadership with an invited group of student leaders.
Five students selected as 2018 Burch Fellows
Five students from the University of North Carolina at Chapel Hill’s College of Arts & Sciences were selected as recipients of the 2018 Burch Fellowship to pursue unique, self-defined educational experiences anywhere outside UNC-Chapel Hill’s campus.
Celebrate the arts on April 6
April 6 will be a day for living the arts, no matter where you go on campus or on Franklin Street.
Developing polymers that mimic chameleon skin
Biological materials have complex mechanical properties that are difficult to reproduce using synthetic materials. An international team of researchers, led by UNC-Chapel Hill chemist Sergei Sheiko, has produced a biocompatible synthetic material that behaves like biological tissues and changes color when it changes shape — like chameleon skin. The research appears in the March 30 issue of Science.
UNC startup Ribometrix pioneers new technology to target RNA, unlock new disease therapies
Today, the majority of drugs and pharmaceuticals on the market that treat human disease are designed to target a specific protein. But University of North Carolina at Chapel Hill startup Ribometrix has a very different, revolutionary approach to new drug discovery that’s proving to be a breakthrough in the industry.
Looking for College stories older than 2018? Visit our news archive.
News Archive